Antipodean Advisors LLC Cardlytics, Inc. Transaction History
Antipodean Advisors LLC
- $18.2 Million
- Q3 2023
A detailed history of Antipodean Advisors LLC transactions in Cardlytics, Inc. stock. As of the latest transaction made, Antipodean Advisors LLC holds 20,000 shares of CDLX stock, worth $74,200. This represents 1.81% of its overall portfolio holdings.
Number of Shares
20,000
Previous 35,000
42.86%
Holding current value
$74,200
Previous $221,000
49.32%
% of portfolio
1.81%
Previous 1.7%
Shares
8 transactions
Others Institutions Holding CDLX
# of Institutions
130Shares Held
31MCall Options Held
1.23MPut Options Held
775K-
Cliff Sosin Cas Investment Partners, LLC | New York, Ny6.42MShares$23.8 Million1.36% of portfolio
-
Black Rock Inc. New York, NY3.15MShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$9.9 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY2.23MShares$8.26 Million0.65% of portfolio
-
Kps Global Asset Management Uk LTD London, X01.22MShares$4.52 Million0.93% of portfolio
About Cardlytics, Inc.
- Ticker CDLX
- Exchange NASDAQ
- Sector Communication Services
- Industry Advertising Agencies
- Shares Outstandng 32,893,800
- Market Cap $122M
- Description
- Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and var...